Dolby Laboratories (DLB) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Dolby Laboratories (DLB) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (88% profit margin, 10% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
How DLB Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $1.35B | 88.1% | 19.6% | $255.0M | $435.9M | 9.5% |
| FY 2024 | $1.27B | 89% | 20.3% | $261.8M | $297.2M | 9% |
| FY 2023 | $1.30B | 44% | 16.6% | $200.7M | $308.6M | 8.7% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring DLB)
- ✓Live walkthrough of DLB's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
DLB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DLB today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for DLB. Explore sector supply chains on /butterfly.
DLB Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Dolby Laboratories (DLB)?
In FY 2025 (10-K), DLB converted $1.3B of revenue into a 88.1% gross margin, 19.6% operating margin, and $435.9M in free cash flow (32.3% FCF margin).